Page last updated: 2024-10-26

diphenyleneiodonium and AIDS Dementia Complex

diphenyleneiodonium has been researched along with AIDS Dementia Complex in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

AIDS Dementia Complex: A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, HY1
Ju, SM1
Seo, WY1
Goh, AR1
Lee, JK1
Bae, YS1
Choi, SY1
Park, J1

Other Studies

1 other study available for diphenyleneiodonium and AIDS Dementia Complex

ArticleYear
Nox2-based NADPH oxidase mediates HIV-1 Tat-induced up-regulation of VCAM-1/ICAM-1 and subsequent monocyte adhesion in human astrocytes.
    Free radical biology & medicine, 2011, Mar-01, Volume: 50, Issue:5

    Topics: AIDS Dementia Complex; Astrocytes; Cell Adhesion; Cell Line, Tumor; Gene Knockdown Techniques; HIV-1

2011